Skip to main content
OpenTrials
Completed

NCT Number: NCT03032159

Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities

Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigators are testing the efficacy of a short message service (SMS)-enhanced health communication (HC) intervention ("Text2Breathe") designed to equip urban, low-income parents with tools for communicating effectively with their children's primary care provider (PCP).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seattle Children's, Seattle, Washington, United States

Loading trial locations.

About this study

Potentially eligible participants are approached and screened in person during an admission of their child to the emergency department for asthma care. Those participants randomized to the intervention will receive additional education on effective communication with their child's primary care provider (PCP). These participants will also receive educational text messages for three months after their initial visit. Text messages will include education on effectively communicating with their child's provider and general asthma information. Both the control group and intervention group will receive text message reminders to schedule regular follow up visits with their PCP and get an annual flu shot. Both groups will be contacted for follow up phone interviews at 3, 6, 12, 18 and 24 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unlimited text messaging

Is the parent of child who is:

  • Receiving asthma related care in the emergency department
  • 2-12 years old inclusive
  • Medicaid insured (no Private insurance)
  • Physician diagnosed asthma for at least 12 months

Exclusion criteria

Is the parent of child who:

  • Has seen a pulmonary or allergy sub-specialist more than once in the last 6 months
  • Has seen a sub-specialist (not pulmonary or allergy) more than once in the last 12 months
  • Has been hospitalized for more than 30 days
  • Is currently enrolled in another asthma program or study

Treatment and study plan

Text2Breathe Study Group

Behavioral

Primary outcomes

  1. Emergency Department Visits for Asthma Care

    Time frame: 12 months

    Number of emergency department visits for asthma care

Secondary outcomes

  1. Asthma Morbidity

    Time frame: 12 months

    Asthma morbidity measured as the number of days (or nights) of impairment.

Other outcomes

  1. Number of Scheduled Asthma Care Visits

    Time frame: 12 months

    Number of visits with PCP for preventative asthma care in past 12 months

  2. Asthma Self-Management Questionnaire Standardized Score

    Time frame: 12 months

    The Asthma Self-Management Questionnaire, recommended by experts convened for the Asthma Outcomes workshop, includes 16 multiple-choice questions regarding knowledge of preventive strategies and controller medication use. Standardized scores (0-100) are generated, with higher scores indicating more knowledge of self-management. Cronbach's alpha was 0.71. Wording of questions has been revised (e.g., "you" = "your child") to be appropriate for parents of children with asthma.

  3. Parental Expectations for Child's Asthma Treatment Average Score

    Time frame: 12 months

    In accordance with other research of pediatric asthma interventions, to assess parents' beliefs about possible asthma quality of life for their child we will administer an 8-item measure of parental expectations for asthma treatment. Parents respond to statements about their expectations (e.g., "I believe that my child can be symptom free most of the time.") using a 5-point Likert scale (1=strongly disagree to 5=strongly agree). Total scores are calculated by averaging across responses, and higher scores reflect more optimistic asthma outcome expectations (Cronbach's alpha = 0.70).

  4. Parental Self-efficacy for Communicating With Healthcare Providers Self-competence Scale Summary Score

    Time frame: 12 months

    The Medical Competence Communication Scale (MCCS) measures patient's perceptions of their own communication during their most recent medical visits. The patient version of the measure is used to assess information giving, seeking and verifying, as well as socio-emotional communication. The MCCS, patient version, consists of 23 items rated on a 5-point Likert scale (1= unimportant to 5= important) with a higher score indicating greater perception of communication competence (range 16-80). Cronbach's alpha ranges from 0.76-0.92 on the various subscales. Only the 16 self-competence items will be administered in this study. Wording of questions will be modified to state "my child's medical problem" rather than "my medical problem."

  5. Parental Asthma Management Self-efficacy Scale Summary Score

    Time frame: 12 months

    The Parent Asthma Management Self-Efficacy Scale (PAMSES) is a valid and reliable instrument designed to measure parent self-efficacy in preventing and managing children's asthma attacks. The PAMSES consists of 13 items rated on a 5-point Likert scale (1=not at all sure to 5=completely sure) with a total possible score range of 13 to 65; higher scores indicate greater self-efficacy. Cronbach's alpha in a sample of primarily White mothers was 0.87.

Sponsors and collaborators

Lead sponsor

Seattle Children's Hospital

Other

Collaborators

  • MultiCare Mary Bridge Children's Hospital & Health Center

Registry information

Acronym: T2B

Important dates

Study start
2015
Primary completion
2020
Study completion
2020
First posted
Jan 26, 2017
Registry last updated
Dec 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.